These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 3624579

  • 21. [Nodular efflorescence and cutaneous vasculitis in rheumatoid arthritis treated with methotrexate].
    Lassoued S, Billey T, Pages M, Dromer C, Fournie B, Fournie A.
    Presse Med; 1992 Mar 07; 21(9):437. PubMed ID: 1533038
    [No Abstract] [Full Text] [Related]

  • 22. Methotrexate in the treatment of vasculitic cutaneous ulceration in rheumatoid arthritis.
    Williams HC, Pembroke AC.
    J R Soc Med; 1989 Dec 07; 82(12):763. PubMed ID: 2614773
    [No Abstract] [Full Text] [Related]

  • 23. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism.
    Halevy S, Giryes H, Avinoach I, Livni E, Sukenik S.
    J Eur Acad Dermatol Venereol; 1998 Jan 07; 10(1):81-5. PubMed ID: 9552765
    [Abstract] [Full Text] [Related]

  • 24. Methotrexate related cutaneous vasculitis.
    Torner O, Ruber C, Olive A, Tena X.
    Clin Rheumatol; 1997 Jan 07; 16(1):108-9. PubMed ID: 9132315
    [No Abstract] [Full Text] [Related]

  • 25. Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers.
    Assmann G, Pfreundschuh M, Voswinkel J.
    Clin Exp Rheumatol; 2010 Jan 07; 28(1 Suppl 57):81-3. PubMed ID: 20412708
    [Abstract] [Full Text] [Related]

  • 26. Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
    Shimura C, Satoh T, Takayama K, Yokozeki H.
    J Am Acad Dermatol; 2009 Jul 07; 61(1):126-9. PubMed ID: 19539849
    [Abstract] [Full Text] [Related]

  • 27. Rheumatoid arthritis: a review of the cutaneous manifestations.
    Sayah A, English JC.
    J Am Acad Dermatol; 2005 Aug 07; 53(2):191-209; quiz 210-2. PubMed ID: 16021111
    [Abstract] [Full Text] [Related]

  • 28. Testicular involvement in rheumatoid vasculitis.
    Mayer DF, Matteson EL.
    Clin Exp Rheumatol; 2004 Aug 07; 22(6 Suppl 36):S62-4. PubMed ID: 15675137
    [Abstract] [Full Text] [Related]

  • 29. Dermatologic conditions reported in patients with rheumatoid arthritis.
    Jorizzo JL, Daniels JC.
    J Am Acad Dermatol; 1983 Apr 07; 8(4):439-57. PubMed ID: 6343438
    [Abstract] [Full Text] [Related]

  • 30. Listeria monocytogenes infection in a patient treated with methotrexate for rheumatoid arthritis.
    Hayem G, Meyer O, Kahn MF.
    J Rheumatol; 1996 Jan 07; 23(1):198-9. PubMed ID: 8838541
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Acquired reactive perforating collagenosis associated with systemic lupus erythematosus.
    Ohashi T, Yamamoto T.
    J Dermatol; 2016 Sep 07; 43(9):1097-9. PubMed ID: 27028318
    [No Abstract] [Full Text] [Related]

  • 33. Sequential appearance of small vessel vasculitis and neutrophilic panniculitis in a patient with rheumatoid arthritis: further insight into the mechanism of this infrequent panniculitis.
    Rodríguez-Jiménez P, Chicharro P, Reolid A, Muñoz-Aceituno E, Fraga J, Llamas-Velasco M.
    Int J Dermatol; 2019 Oct 07; 58(10):e198-e200. PubMed ID: 31209861
    [No Abstract] [Full Text] [Related]

  • 34. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
    Choi BR, Ahn MJ, Lee WS, Kim TH, Bae SC, Jun JB.
    Rheumatol Int; 2005 May 07; 25(4):311-3. PubMed ID: 15338190
    [Abstract] [Full Text] [Related]

  • 35. [The rheumatoid vasculitis and malignant rheumatoid arthritis(MRA)].
    Matsumoto Y.
    Nihon Rinsho; 2002 Dec 07; 60(12):2408-16. PubMed ID: 12510370
    [Abstract] [Full Text] [Related]

  • 36. [Dermatologic conditions & nail manifestations in rheumatoid arthritis].
    Yoshida H, Yoshida S.
    Nihon Rinsho; 2005 Jan 07; 63 Suppl 1():225-8. PubMed ID: 15799350
    [No Abstract] [Full Text] [Related]

  • 37. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis.
    Maruani A, Wierzbicka E, Machet MC, Abdallah-Lotf M, de Muret A, Machet L.
    J Am Acad Dermatol; 2007 Nov 07; 57(5 Suppl):S69-71. PubMed ID: 17938029
    [Abstract] [Full Text] [Related]

  • 38. Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis.
    Jeurissen ME, Boerbooms AM, van de Putte LB.
    Clin Rheumatol; 1989 Sep 07; 8(3):417-9. PubMed ID: 2805620
    [No Abstract] [Full Text] [Related]

  • 39. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.
    Wollner A, Mohle-Boetani J, Lambert RE, Perruquet JL, Raffin TA, McGuire JL.
    Thorax; 1991 Mar 07; 46(3):205-7. PubMed ID: 2028435
    [Abstract] [Full Text] [Related]

  • 40. Elevated plasma levels of beta-thromboglobulin and platelet factor 4 in patients with rheumatic disorders and cutaneous vasculitis.
    Yamamoto T, Chikugo T, Tanaka Y.
    Clin Rheumatol; 2002 Nov 07; 21(6):501-4. PubMed ID: 12447635
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.